J1932 HCPCS code: Injection, lanreotide, (cipla), 1 mg
J1932 is the HCPCS Level II code for injection, lanreotide, (cipla), 1 mg. In 2024 Medicare paid an average of $34.40 per service for J1932 across 508,174 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 120 per day on DME suppliers. Medicare volume rose 817% from 2022 to 2024 (55,443 to 508,174 services). In 2024, about 542 clinicians billed Medicare for J1932 for 667 beneficiaries; Florida, California, Arkansas accounted for 82% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2022-10-01 |
| Last action effective | 2022-10-01 |
Who bills J1932 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 542 |
| Medicare beneficiaries | 667 |
| States with claims | 12 |
| Share of services in top 3 states (Florida, California, Arkansas) | 82% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1932, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 55,443 | 244 | $59.65 | $47.53 |
| 2023 | 444,811 | 724 | $53.59 | $42.66 |
| 2024 | 508,174 | 667 | $43.24 | $34.40 |
States with the most J1932 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 285,720 | $34.16 |
| California | 65,972 | $35.07 |
| Arkansas | 26,040 | $34.08 |
| Arizona | 21,360 | $34.71 |
| Maryland | 13,320 | $35.16 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 120 | Prescribing Information |
| outpatient hospital claims | 120 | Prescribing Information |
| practitioner claims | 120 | Prescribing Information |
What changed for J1932
- 2022-10-01: J1932 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1932?
J1932 is the HCPCS Level II code for injection, lanreotide, (cipla), 1 mg. Short descriptor: "Inj, lanreotide, (cipla) 1mg".
How much does Medicare pay for J1932?
In 2024, the average Medicare payment was $34.40 per service (average allowed $43.24).
Does Medicare cover J1932?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J1932 can be billed per day?
120 on DME suppliers; 120 on outpatient hospital claims; 120 on practitioner claims (NCCI medically unlikely edits).
Related J19 codes
- J1920 — Injection, labetalol hydrochloride, 5 mg
- J1921 — Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg
- J1930 — Injection, lanreotide, 1 mg
- J1931 — Injection, laronidase, 0.1 mg
- J1938 — Injection, furosemide, 1 mg
- J1939 — Injection, bumetanide, 0.5 mg
- J1940 — Injection, furosemide, up to 20 mg
- J1941 — Injection, furosemide (furoscix), 20 mg
- J1942 — Injection, aripiprazole lauroxil, 1 mg
- J1943 — Injection, aripiprazole lauroxil, (aristada initio), 1 mg
- J1944 — Injection, aripiprazole lauroxil, (aristada), 1 mg
- J1945 — Injection, lepirudin, 50 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1932
- Watch J1932 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1932
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.